Progyny Inc. (PGNY)
NASDAQ: PGNY
· Real-Time Price · USD
22.55
-1.01 (-4.29%)
At close: Sep 05, 2025, 3:59 PM
22.50
-0.22%
After-hours: Sep 05, 2025, 07:55 PM EDT
Progyny Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fertility benefit services revenue Revenue | 213.94M | 206.41M | 381.02M | 178.76M | 193.56M | 169.77M | 171.3M | 175.11M | 172.74M | 157.15M | 143.14M | 129.3M | 126.79M | 110.92M | 89.18M | 85.31M | 92.27M |
| Fertility benefit services revenue Revenue Growth | +3.65% | -45.83% | +113.15% | -7.65% | +14.02% | -0.89% | -2.17% | +1.37% | +9.92% | +9.79% | +10.70% | +1.98% | +14.31% | +24.37% | +4.54% | -7.54% | n/a |
| Pharmacy benefit services revenue Revenue | 118.93M | 117.63M | 221.49M | 107.87M | 110.52M | 108.31M | 98.64M | 105.78M | 106.64M | 101.25M | 71.19M | 76.07M | 68.21M | 61.3M | 38.37M | 36.97M | 36.38M |
| Pharmacy benefit services revenue Revenue Growth | +1.10% | -46.89% | +105.34% | -2.40% | +2.05% | +9.80% | -6.75% | -0.80% | +5.32% | +42.23% | -6.42% | +11.52% | +11.28% | +59.76% | +3.78% | +1.61% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 54.62M | 51.63M | 47.65M | 46.79M | 47.59M | 43.88M | 43.09M | 44.44M | 45.46M | 43.63M | 41.19M | 34.74M | 35.05M | 33.01M | 25.3M | 19.43M | 17.96M | 17.1M | 19.5M | 15.47M | 13.78M | 12.74M | 10.63M | 9.25M | 9.1M | 6.85M | 6.12M | 5.63M | 5.36M | 5.78M |
| Selling, General, and Administrative Revenue Growth | +5.79% | +8.35% | +1.84% | -1.70% | +8.46% | +1.83% | -3.02% | -2.25% | +4.19% | +5.93% | +18.56% | -0.88% | +6.19% | +30.45% | +30.25% | +8.14% | +5.06% | -12.33% | +26.04% | +12.34% | +8.10% | +19.93% | +14.85% | +1.68% | +32.74% | +12.03% | +8.59% | +5.21% | -7.34% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 18.41M | 17.79M | 15.62M | 16.46M | 16.42M | 15.45M | 14.91M | 14.91M | 15.38M | 14.28M | 12.98M | 11.17M | 11.5M | 10.02M | 7.7M | 4.44M | 4.03M | 4.01M | 4.78M | 3.35M | 3.61M | 3.27M | 3.25M | 3.18M | 3.12M | 2.35M | 2.14M | 1.65M | 1.73M | 1.76M |
| Sales and Marketing Revenue Growth | +3.48% | +13.90% | -5.11% | +0.22% | +6.26% | +3.64% | 0.00% | -3.07% | +7.72% | +10.03% | +16.25% | -2.87% | +14.79% | +30.13% | +73.29% | +10.25% | +0.35% | -15.95% | +42.35% | -7.01% | +10.44% | +0.37% | +2.26% | +2.12% | +32.86% | +9.47% | +30.04% | -4.79% | -1.82% | n/a |